Hosts Anna and Andy mark two years since Dr Michele Afif became Chief Executive at The Brain Tumour Charity by asking about her early life, her previous careers in medicine and law - and a few more questions that we crowdsourced from our listeners. In response, Michele explains how she's focused The Charity on turning its co-created strategy into a 'strategy in action'. She's honed in on what it needs to deliver, what evidence backs that up and how it can deliver truly transformative re...
All content for Let's Talk About Brain Tumours is the property of The Brain Tumour Charity and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Hosts Anna and Andy mark two years since Dr Michele Afif became Chief Executive at The Brain Tumour Charity by asking about her early life, her previous careers in medicine and law - and a few more questions that we crowdsourced from our listeners. In response, Michele explains how she's focused The Charity on turning its co-created strategy into a 'strategy in action'. She's honed in on what it needs to deliver, what evidence backs that up and how it can deliver truly transformative re...
Anna talks to Anna Solth and Victoria Wyes about their experiences of being neurosurgeons and women in the field of neuroscience. They share their passion for neuroscience, discuss the work they are doing now and their plans for the future.Better Safe Than Tumour Money Advice ClinicIf you would like to speak to a member of our support team you can call 0808 800 0004 or email support@thebraintumourcharity.org
Let's Talk About Brain Tumours
Hosts Anna and Andy mark two years since Dr Michele Afif became Chief Executive at The Brain Tumour Charity by asking about her early life, her previous careers in medicine and law - and a few more questions that we crowdsourced from our listeners. In response, Michele explains how she's focused The Charity on turning its co-created strategy into a 'strategy in action'. She's honed in on what it needs to deliver, what evidence backs that up and how it can deliver truly transformative re...
